Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
329.199093735
InChI
InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1
InChI Key
InChIKey=KVJXBPDAXMEYOA-CXANFOAXSA-N
IUPAC Name
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile
Traditional IUPAC Name
trilostane
SMILES
[H][C@]12O[C@]11CC[C@@]3([H])[C@]4([H])CC[C@H](O)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CC(C#N)=C2O
pKa (strongest acidic)
5.23
pKa (Strongest Basic)
-0.88
Refractivity
90.17 m3·mol-1
Dược Lực Học :
Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland. This product was withdrawn from the U.S. market in April 1994.
Cơ Chế Tác Dụng :
Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994. [Wikipedia]
Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.
Dược Động Học :
▧ Metabolism :
Hepatic.
▧ Half Life :
8 hours.
Độc Tính :
Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.
Chỉ Định :
Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Desopan
-
Sản phẩm biệt dược : Modrastane
-
Sản phẩm biệt dược : Modrenal